Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2017

Sep 23, 2017

32853_dirs_2017-09-22_c6e1af6a-23f7-40d0-b55b-b992df741960.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2017-09-20

Reporting Person: LEE JENNIFER LING (See Remarks)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-20 Employee Stock Option (Right to Buy) $8.98 D 13400 Disposed 2026-05-18 Common Stock (13400.0) Direct
2017-09-20 Employee Stock Option (Right to Buy) $5.13 A 7053 Acquired 2027-09-20 Common Stock (7053.0) Direct

Footnotes

F1: The Option provided for vesting of 12/48th of the total number of shares subject to the Option on May 20, 2017 and thirty-six equal monthly installments beginning on June 20, 2017.

F2: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,400 shares of FLDM common stock granted to the Reporting Person on May 18, 2016. In exchange, the Reporting Person received a replacement Option, for 7,053 shares, having an exercise price of $5.13 per share.

F3: 1/12th of the total number of shares subject to the Option will vest on February 20, 2018, and 1/12th of the total number of shares subject to the Option will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.